Literature DB >> 6653639

Rapid achievement of a serum concentration plateau of digoxin through controlled infusion.

M Weiss, W Sziegoleit, A Fahr, W Förster.   

Abstract

Using a volume-controlled infusion pump, a mean serum plateau level of digoxin of 4-5 ng/ml was rapidly achieved and maintained in 6 healthy volunteers. The infusion scheme was calculated on the basis of data published on the pharmacokinetics and pharmacodynamics of digoxin following bolus intravenous injection. The magnitude of the response (change in electromechanical systole) at the end of the plateau phase was comparable to that observed with the concentration in the therapeutic range at steady state.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653639     DOI: 10.1007/BF00542110

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.

Authors:  D P Vaughan; G T Tucker
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

2.  A general method for optimal drug dose computation.

Authors:  L A Wheeler; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1976-12

3.  [Determination of digoxin in serum. Comparison of radioimmunoassay and a heterogeneous enzyme immunoassay (author's transl)].

Authors:  K Borner; N Rietbrock
Journal:  J Clin Chem Clin Biochem       Date:  1978-06

4.  Pharmacokinetics of digoxin: relationship between response intensity and predicted compartmental drug levels in man.

Authors:  W G Kramer; A J Kolibash; R P Lewis; M S Bathala; J A Visconti; R H Reuning
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

5.  A safe method for rapidly achieving plasma concentration plateaus.

Authors:  J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

6.  Continuous intravenous infusion and multicompartment accumulation.

Authors:  E Krüger-Thiemer
Journal:  Eur J Pharmacol       Date:  1968-10       Impact factor: 4.432

7.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

8.  A general method for calculating the dosage scheme in linear pharmacokinetics.

Authors:  H Schwilden
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  8 in total
  5 in total

1.  All half-lives are wrong, but some half-lives are useful.

Authors:  J G Wright; A V Boddy
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Inotropic effect of digoxin in humans: mechanistic pharmacokinetic/pharmacodynamic model based on slow receptor binding.

Authors:  Michael Weiss; Wonku Kang
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

3.  The acute effects of amiloride and potassium canrenoate on digoxin-induced positive inotropism in healthy volunteers.

Authors:  J P Richter; D K Sommers; J R Snyman; S M Millard
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Digoxin infusion versus bolus injection in rapid atrial fibrillation: relation between serum level and response.

Authors:  A J Smit; A H Scaf; L H van Essen; K I Lie; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.

Authors:  Björn Hornestam; Markus Jerling; Mats O Karlsson; Peter Held
Journal:  Eur J Clin Pharmacol       Date:  2003-02-19       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.